|
Atripla (efavirenz, emtricitabine, tenofovir) Information
FDA has approved Atripla (efavirenz, emtricitabine, tenofovir), a fixed dose combination of three widely used antiretroviral drugs, to be taken as one tablet once a day. Atripla is indicated for use alone as a complete treatment option or in combination with other antiretroviral agents for the treatment of human immunodeficiency virus -1 (HIV-1) infection in adult patients.
Back to Drug Information
 PDF requires the free Adobe
Acrobat Reader
Date created: July 12, 2006 |
